BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (NASDAQ:AIMT), a biopharmaceutical company developing desensitization treatments for food allergies, today announced that members of the senior management team will present a company overview at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8, 2016, at 11:20 a.m. Eastern Time and at the Barclays Capital Global Healthcare Conference on Wednesday, March 16, 2016, at 4:20 p.m. Eastern Time.
